Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

ANTXANTX
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in AN2 THERAPEUTICS INC

BANK OF AMERICA CORP /DE/ holds 145,803 shares of ANTX (AN2 THERAPEUTICS INC), worth $705,686 as of 2026-Q2. The position was decreased (-63.0% shares).

Current Value

$705,686

Current Shares

145,803

Total Value Change

+$173,730

Total Shares Change

-239,672

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
145,803
-63.0%
$705,6860.0%$4.84
0
2026-Q1
Increased
393,702
+2.2%
$1.3M0.0%$1.06
26
2025-Q4
Increased
385,312
0.0%
$439,2560.0%$1.08
16
2025-Q3
Decreased
385,310
-0.1%
$489,3430.0%$1.28
0
2025-Q2
Increased
385,511
+0.0%
$408,6420.0%$1.08
16
2025-Q1
Increased
385,483
0.0%
$524,2570.0%$1.39
16
2024-Q4
New
385,475
-
$531,9560.0%$1.41
37

Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used